These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24440890)

  • 1. Tiagabine-induced stupor - more evidence for an encephalopathy.
    Hamandi K; Myers J; Muthukumaraswamy S
    Epilepsy Behav; 2014 Feb; 31():196-7. PubMed ID: 24440890
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiagabine-induced stupor in patients with psychogenic nonepileptic seizures: nonconvulsive status epilepticus or encephalopathy?
    Azar NJ; Bangalore-Vittal N; Arain A; Abou-Khalil BW
    Epilepsy Behav; 2013 May; 27(2):330-2. PubMed ID: 23524471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status epilepticus due to tiagabine ingestion.
    Leikin JB; Benigno J; Dubow JS; Fisher M
    Am J Ther; 2008; 15(3):290-1. PubMed ID: 18496267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy.
    Ettinger AB; Bernal OG; Andriola MR; Bagchi S; Flores P; Just C; Pitocco C; Rooney T; Tuominen J; Devinsky O
    Epilepsia; 1999 Aug; 40(8):1159-62. PubMed ID: 10448832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis that tiagabine-induced NCSE is associated with GABAergic hyperfunction, with GABA(B) receptors playing a critical role, is supported by a case of generalized NCSE induced by baclofen.
    Solomon GE; Labar D
    Epilepsia; 1998 Dec; 39(12):1383. PubMed ID: 9860080
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced nonconvulsive status epilepticus with low dose of tiagabine.
    Fitzek S; Hegemann S; Sauner D; Bönsch D; Fitzek C
    Epileptic Disord; 2001 Sep; 3(3):147-50. PubMed ID: 11679307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure.
    Zhu Y; Vaughn BV
    Seizure; 2002 Jan; 11(1):57-9. PubMed ID: 11888262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment.
    Skodda S; Kramer I; Spittler JF; Gehlen W
    J Neurol; 2001 Feb; 248(2):109-12. PubMed ID: 11284127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients.
    Balslev T; Uldall P; Buchholt J
    Eur J Paediatr Neurol; 2000; 4(4):169-70. PubMed ID: 11008259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tiagabine and non-convulsive status epilepticus].
    Holtkamp M; Pfeiffer M; Buchheim K; Meierkord H
    Nervenarzt; 1999 Dec; 70(12):1104-6. PubMed ID: 10637817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature.
    Kellinghaus C; Dziewas R; Lüdemann P
    Seizure; 2002 Jun; 11(4):243-9. PubMed ID: 12027571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment.
    Eckardt KM; Steinhoff BJ
    Epilepsia; 1998 Jun; 39(6):671-4. PubMed ID: 9637612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient.
    Mangano S; Cusumano L; Fontana A
    Brain Dev; 2003 Oct; 25(7):518-21. PubMed ID: 13129597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
    Brouns R; Van Paesschen W
    Acta Neurol Belg; 2002 Mar; 102(1):19-20. PubMed ID: 12094558
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonconvulsive status epilepticus due to a de novo contralateral focus during tiagabine adjunctive therapy.
    Imperiale D; Pignatta P; Cerrato P; Montalenti E; Ravetti C; Benna P
    Seizure; 2003 Jul; 12(5):319-22. PubMed ID: 12810347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine-induced absence status in idiopathic generalized epilepsy.
    Knake S; Hamer HM; Schomburg U; Oertel WH; Rosenow F
    Seizure; 1999 Aug; 8(5):314-7. PubMed ID: 10486298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient.
    Vollmar C; Noachtar S
    Neurology; 2007 Jan; 68(4):310. PubMed ID: 17242344
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile].
    Kellinghaus C; Loddenkemper T; Weitemeyer L; Lüdemann P
    Nervenarzt; 2001 Oct; 72(10):764-9. PubMed ID: 11688177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-convulsive status epilepticus associated with tiagabine therapy in children.
    Skardoutsou A; Voudris KA; Vagiakou EA
    Seizure; 2003 Dec; 12(8):599-601. PubMed ID: 14630501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy.
    Jette N; Cappell J; VanPassel L; Akman CI
    Neurology; 2006 Oct; 67(8):1514-5. PubMed ID: 17060592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.